Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 12/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3369754 | 0.95 | EPHX1 (0.54) | EPHX1ACHEALDH1A1RAB9ANAAA | |
| SCHEMBL3368234 | 0.95 | EPHX1 (0.54) | EPHX1ACHEALDH1A1RAB9ANAAA | |
| SCHEMBL994563 | 0.93 | RAB9A (0.55) | EPHX1ALDH1A1RAB9AL3MBTL1 | |
| SCHEMBL7158889 | 0.92 | EPHX1 (0.50) | EPHX1ACHEALDH1A1RAB9AL3MBTL1 | |
| SCHEMBL2903601 | 0.88 | RAB9A (0.51) | ALDH1A1RAB9AL3MBTL1 | |
| SCHEMBL6675218 | 0.88 | TSHR (0.56) | ALDH1A1RAB9AL3MBTL1 | |
| SCHEMBL2906397 | 0.88 | RAB9A (0.51) | ALDH1A1RAB9AL3MBTL1 | |
| SCHEMBL6578691 | 0.86 | TSHR (0.51) | ALDH1A1RAB9AL3MBTL1 | |
| SCHEMBL3365548 | 0.85 | SMN1; SMN2 (0.49) | ALDH1A1RAB9AL3MBTL1CSNK2A2CSNK2A1 | |
| SCHEMBL2907201 | 0.85 | RAB9A (0.49) | ALDH1A1RAB9AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1440065-B1 | METHOD FOR PREPARING ALKOXYCARBONYLAMINO-TRIAZINES | BASF SE (DE) | 2010-10-06 | — | — | EP | disclosed |
| US-7371856-B2 | Preparation of alkoxycarbonylaminotriazines | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-13 | — | — | US | disclosed |
| US-20070083047-A1 | Preparation of Alkoxycarbonylaminotriazines | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-7169923-B2 | Method for preparing alkoxycarbonylamino-triazines | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
| US-20040249149-A1 | Method for preparing alkoxycarbonylamino-triazines | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-09 | — | — | US | disclosed |
| EP-1440065-A1 | METHOD FOR PREPARING ALKOXYCARBONYLAMINO-TRIAZINES | BASF AKTIENGESELLSCHAFT (DE) | 2004-07-28 | — | — | EP | disclosed |
| WO-2003035628-A1 | METHOD FOR PREPARING ALKOXYCARBONYLAMINO-TRIAZINES | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249149-A1 | Method for preparing alkoxycarbonylamino-triazines | ADH1C, PNMT, TET2 | EPHX1 3447/4885ACHE 2525/4885ALDH1A1 1418/4885 |
| US-20070083047-A1 | Preparation of Alkoxycarbonylaminotriazines | ADH1C, TET2, PNMT | EPHX1 3541/4885ACHE 2886/4885ALDH1A1 1513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.